Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has submitted the soft copy of the Annual Report of the Company for the Financial Year 2019-20. The 32nd Annual General Meeting of the Company scheduled on 30th September, 2020 to be held through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The above information is a part of company’s filings submitted to BSE.